The A.I. story nobody is telling you (Read ASAP)

There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...

Click here to see Louis' new video for yourself.

Gilbert Fuller Biography and Net Worth

Director of USANA Health Sciences

Gilbert A. Fuller has served as a director of USANA since September 2008. Prior to that, he served as our Executive Vice President, Chief Financial Officer, and Secretary since January 2006. Mr. Fuller joined USANA in May 1996, as the Vice President of Finance and served in this role until June 1999, when he was appointed as the Company's Senior Vice President. Before joining USANA, Mr. Fuller served in various executive positions for several companies. Mr. Fuller served as Chief Administrative Officer and Treasurer of Melaleuca, Inc., a manufacturer, and direct seller of personal care products. He was also the Vice President and Treasurer of Norton Company, a multinational manufacturer of ceramics and abrasives. He obtained his certified public accountant license in 1970 and kept it current until his career path developed into corporate finance. Mr. Fuller received a B.S. in Accounting and an M.B.A. from the University of Utah. In December 2012, Mr. Fuller was appointed as a director of Security National Financial Corporation, a NASDAQ-listed company.

What is Gilbert A. Fuller's net worth?: The estimated net worth of Gilbert A. Fuller is at least $608,204.41 as of April 2nd, 2024. Mr. Fuller owns 14,141 shares of USANA Health Sciences stock worth more than $608,204 as of April 18th. This net worth evaluation does not reflect any other investments that Mr. Fuller may own. Learn More about Gilbert A. Fuller's net worth.
How do I contact Gilbert A. Fuller?: The corporate mailing address for Mr. Fuller and other USANA Health Sciences executives is 3838 West Parkway Blvd, Salt Lake City UT, 84120. USANA Health Sciences can also be reached via phone at (801) 954-7100 and via email at [email protected]. Learn More on Gilbert A. Fuller's contact information.
Has Gilbert A. Fuller been buying or selling shares of USANA Health Sciences?: Gilbert A. Fuller has not been actively trading shares of USANA Health Sciences during the past quarter. Most recently, Gilbert A. Fuller sold 490 shares of the business's stock in a transaction on Friday, November 3rd. The shares were sold at an average price of $46.01, for a transaction totalling $22,544.90. Learn More on Gilbert A. Fuller's trading history.
Who are USANA Health Sciences' active insiders?: USANA Health Sciences' insider roster includes Robert Auciaux (Director), Jim Brown (President), John Fleming (Director), Joshua Foukas (Insider), Gilbert Fuller (Director), G. Iiekking (CFO), Daniel Macuga (Insider), David Mulham (Insider), Brent Neidig (Insider), Walter Noot (COO), Feng Peng (Director), Robert Sinnott (Insider), Myron Wentz (Major Shareholder), and Frederic Winssinger (Director). Learn More on USANA Health Sciences' active insiders.
Are insiders buying or selling shares of USANA Health Sciences?: In the last twelve months, insiders at the sold shares 20 times. They sold a total of 59,164 shares worth more than $3,449,714.61. The most recent insider tranaction occured on March, 11th when Chairman Kevin Guest sold 11,011 shares worth more than $539,539.00. Insiders at USANA Health Sciences own 0.3% of the company. Learn More about insider trades at USANA Health Sciences.
Information on this page was last updated on 3/11/2024.

Gilbert A. Fuller Insider Trading History at USANA Health Sciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/3/2023	Sell	490	$46.01	$22,544.90
7/31/2023	Sell	226	$65.01	$14,692.26	265
2/16/2023	Sell	404	$61.85	$24,987.40
11/8/2022	Sell	404	$52.11	$21,052.44
7/29/2022	Sell	404	$70.00	$28,280.00
5/20/2022	Sell	312	$68.25	$21,294.00
2/15/2022	Sell	312	$89.62	$27,961.44
11/1/2021	Sell	312	$98.40	$30,700.80
8/5/2021	Sell	312	$96.52	$30,114.24
5/5/2021	Sell	426	$93.08	$39,652.08
2/16/2021	Sell	426	$91.54	$38,996.04
10/26/2020	Sell	426	$83.87	$35,728.62
2/6/2020	Sell	329	$79.12	$26,030.48	1,270
10/29/2019	Sell	330	$74.32	$24,525.60
7/26/2019	Sell	329	$66.60	$21,911.40
5/6/2019	Sell	282	$86.58	$24,415.56
2/11/2019	Sell	282	$110.20	$31,076.40
11/5/2018	Sell	282	$113.54	$32,018.28
10/26/2017	Sell	1,710	$67.01	$114,587.10	1,710
7/31/2017	Sell	1,483	$57.67	$85,524.61	1,483
5/11/2017	Sell	4,884	$64.38	$314,431.92	4,884
8/1/2016	Sell	859	$137.07	$117,743.13
2/24/2016	Sell	728	$113.22	$82,424.16	728

Gilbert A. Fuller Buying and Selling Activity at USANA Health Sciences

USANA Health Sciences Company Overview

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.

Today's Range

Now: $43.01

$42.99

$44.20

50 Day Range

MA: $47.95

$43.01

$52.36

2 Week Range

Now: $43.01

$42.59

$69.60

Volume

73,986 shs

Average Volume

79,474 shs

Market Capitalization

$827.51 million

P/E Ratio

13.03

Dividend Yield

N/A

Beta

0.91